Part 3
This is the third post in a 3-part series. Below, we describe Example 49 which focuses on using AI to assist with a medical treatment.
Example 49. Fibrosis Treatment
Key Takeaway for Claim 1: Example 49, Claim
IP Brief
Blog Authors
Latest from IP Brief
Get Ready for Changes to USPTO Trademark Proceedings and Fees in January 2025

Effective January 18, 2025, the United States Patent and Trademark Office (“USPTO”) will update some of its trademark proceedings and fees. The changes aim to provide the USPTO with the additional funding needed to continue to improve its operations and…
Part 2: Key Takeaways from Claim Examples in the 2024 AI Patent Eligibility Guidance
This is the second post in a 3-part series. Example 48 is described below, which is directed to analyzing speech signals and separating desired speech from extraneous or background speech using AI.
Example 48. Speech Separation
Key Takeaway for…
Key Takeaways from Claim Examples in the 2024 AI Patent Eligibility Guidance: A 3-Part Series
Part 1
On July 17, 2024, the U.S. Patent and Trademark Office (the Office) released new guidance on subject matter eligibility, entitled “The 2024 Patent Subject Matter Eligibility Guidance Update Including on Artificial Intelligence” (2024 AI SME Update). The…
Oh, My God (OMG)! – Scandalous Trademarks in Canada (and the US)
“Scandal is gossip made tedious by morality.”- O Wilde
In crafting Valley of Mother of God Gin, the founders of Foxglove Spirits, Malcolm Roberts and Shelly Perry, drew inspiration from the lush forests and fields surrounding their Ontario farm property.…
Amazon’s Patent Enforcement Program Establishes Personal Jurisdiction

The Amazon Patent Evaluation Express (APEX) program offers patent owners a cost-effective way to address claims that third-party product listings are infringing on their utility patents. Under the APEX program, a third-party arbitrator assesses whether a product available on Amazon.com…
Terminal Disclaimer Rule Proposed to Balance Innovation and Competition
The United States Patent and Trademark Office (“USPTO”) periodically evaluates the delicate balance of the U.S. patent system to protect innovation without excessively stifling competition. U.S. patents give patent owners the exclusive right to exclude others from making, using, selling,…
Artificial Incompetence: How Generative AI Creates Latent Intellectual Property Issues
Previously Published in The Journal of Robotics, Artificial Intelligence & Law, Volume 7, No. 3 | May-June 2024
In this article, the authors examine the extensive legal risks that companies take when using generative artificial intelligence (GenAI), particularly within operations…
Accelerating Innovation for New Inventors: Inside the First-Time Filer Expedited Patent Pilot Program
Most inventors can attest to the surprise they felt upon learning that the United States Patent and Trademark Office (USPTO) likely will not respond to their first patent application for a couple of years after filing. To address this concern,…
Getting Off on the Wrong Foot: How Marketing Strategies Can Backfire
The European Court of Justice affirmed an earlier decision of the European Intellectual Property Office (EUIPO) in a case where Puma was attempting to gain a European Union (EU) Community Design on its “Puma Creeper Shoe.” On March 6, 2024,…